.png){kind=icon}
.png){kind=icon}
Return
Composite Dissolvable Microneedle-Enabled Local High-Dose Delivery of Endogenous Thiols for Efficient Allergic Dermatitis Treatment
.png){kind=icon}
PRE
AI
L
Z
Z
W
X
X
L
X
J
DOI：10.1002/cbic.70455.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Allergic dermatitis (AD) requires long-term management, yet conventional systemic therapies are frequently limited by adverse effects and inadequate lesion-specific delivery. Herein, we report a mechanically reinforced composite dissolvable microneedle (MN) patch (L-Cys@HAMN) for localized endogenous thiol delivery in AD treatment. The patch consists of L-cysteine-loaded hyaluronic acid (HA) microneedle tips integrated with an elastic poly(n-butyl acrylate) (PBA) backing layer, enabling efficient force transmission and consistent skin penetration while minimizing structural deformation. Upon insertion, the dissolvable MN tips rapidly release L-cysteine into the viable epidermis, where it is enzymatically converted into hydrogen sulfide (H2S) to suppress inflammatory responses. In vitro studies demonstrated significant downregulation of proinflammatory cytokines, including TNF-α and IL-6. In a passive cutaneous anaphylaxis mouse model, L-Cys@HAMN markedly alleviated inflammatory infiltration and reduced local inflammatory burden compared with control treatments. In addition, the HA-based matrix provided auxiliary moisturizing and barrier-supporting effects. Collectively, this work presents a mechanically robust and therapeutically effective MN platform for localized endogenous thiol delivery and offers a promising strategy for AD management.
Keywords:
allergic dermatitis
dissolvable microneedle
endogenous thiols
hydrogen sulfide
Journal
IF:
2.8
Papers:
854
Citations:
1.5W
Organization
Cited Papers